EP2827885

NOVO NORDISK
Application Number
EP13709231A
Filing Date
Mar 15, 2013
Status
Revoked
Nov 22, 2024
Grant Date
Aug 15, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2827885B1 was granted to Novo Nordisk on Aug 15, 2018 following the initial filing on Mar 15, 2013 under the application number EP13709231A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GALENICUM HEALTH SLUMay 15, 2019ADMISSIBLE
GENERICS UKMay 15, 2019ADMISSIBLE
HEXALMay 15, 2019ADMISSIBLE
TEVA PHARMACEUTICALSMay 13, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents